Endologix secures FDA approval for Powerlink XL System

10/20/2008 | Pharmaceutical Business Review Online

The FDA has cleared Endologix's premarket approval supplement for its Powerlink XL System, allowing the product's use in treating abdominal aortic aneurysms in patients with proximal aortic necks that measure between 23 millimeters and 32 millimeters. The system features suprarenal stent grafts and the Powerlink XL stent graft.

View Full Article in:

Pharmaceutical Business Review Online

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Behavioral Health Operations
Meridian Health Plan
Detroit, MI
Medical Director
Bend, OR
Clinical Appeals RN
Brooklyn, NY
Director of Clinical Operations
Meridian Health Plan
Detroit, MI
Sr. Director, Regulatory Compliance Intelligence and Outreach
Johnson & Johnson
New Brunswick, NJ